1. Home
  2. CRAI vs MGTX Comparison

CRAI vs MGTX Comparison

Compare CRAI & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

N/A

Current Price

$171.55

Market Cap

1.2B

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$14.80

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRAI
MGTX
Founded
1965
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
CRAI
MGTX
Price
$171.55
$14.80
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$245.00
$24.57
AVG Volume (30 Days)
109.8K
556.5K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
1.48%
N/A
EPS Growth
20.77
33.02
EPS
8.14
1.30
Revenue
$751,583,000.00
$81,391,000.00
Revenue This Year
$7.82
$141.38
Revenue Next Year
$5.14
N/A
P/E Ratio
$21.57
$11.41
Revenue Growth
9.33
144.57
52 Week Low
$132.17
$6.62
52 Week High
$227.29
$15.35

Technical Indicators

Market Signals
Indicator
CRAI
MGTX
Relative Strength Index (RSI) 53.73 70.15
Support Level $170.00 $7.04
Resistance Level $179.62 $15.35
Average True Range (ATR) 6.18 0.73
MACD -0.35 0.19
Stochastic Oscillator 58.47 96.65

Price Performance

Historical Comparison
CRAI
MGTX

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: